News | March 06, 2023
Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
New facility is based at Lonza’s Bend, Oregon (US) site, a Center of Excellence for bioavailability enhancement
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Expanded capacity in Nansha, China will support mid-scale manufacturing to ensure a smooth transition between early-phase and large-scale commercial production
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Subscribe To Our Newsletter & Stay Updated
